MVision AI
News and Articles

Keep up to date with our latest articles

Hot Topics 🔥

Press Room

24.3.2022

Outcomes of SABR for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common types of cancer diagnosed in the UK. About 41,000 people get cancer in the large bowel each year in the UK. In 2020, the WHO reported that colorectal cancer accounted for 10% of the cancers diagnosed annually. (Global Cancer Observatory) This…

Articles

18.3.2022

Indications and Effects of SABR for Renal Cancer

Renal cell carcinoma (RCC), generally referred to as Kidney Cancer, is among the ten most common cancers for men and women. The lifetime risk for developing RCC in men is about 1 in 46 and 1 in 80 for women. The American Cancer Society estimates about 79,000 new diagnoses and…

News

24.2.2022

What is Supervised and Unsupervised Machine Learning?

Machine learning has become vital to the modern world, turning data into real, actionable insights. In radiotherapy, there has been a continuous increase in patient-specific needs met with the help of artificial intelligence, from quality personalized treatment to medical imaging.  In the machine learning field, there are two main types…

News

10.2.2022

New Year, New Patient Backlog: RT in the UK

In 2021, reports showed that cancer patients wait up to 62 days for the first dose of radiotherapy treatment in the UK. The numbers of cancer patients facing these delays have hit record highs over the last year. Just last month, NHS Wales reported that numbers on waiting lists for…

Articles

19.1.2022

MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki - 19th of January, 2022 - MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development…

News, Press Releases

7.1.2022

What guidelines do clinicians follow for breast contouring?

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…

News

29.12.2021

2021 MVision AI Re-cap: The Year of GCAIS™

2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…

News

9.12.2021

Medron Medical Systems Inc. is Introducing MVision’s Groundbreaking Auto-Segmentation Solution to Canada

Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new distribution partnership with Medron Medical Systems, Canada’s choice health equipment provider (subject to approval from Health Canada). (more…)

News, Press Releases

3.12.2021

Important Methods for Radiotherapy Treatment

 60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is to destroy cancer cells and slow tumor growth while limiting the harm to nearby healthy tissue. When it is not possible to destroy all of…

News

24.11.2021

SBRT as an Effective Modality for Lung Cancer Treatment

Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…

News

17.11.2021

Examining the Capacity of Radiotherapy to Treat Lung Cancer

Radiotherapy is an important modality used for the treatment of lung cancer. Nearly 80% of all patients with lung cancer have an evidence-based indication for radiotherapy. (Vinod, Shalini K., and Eric Hau.) If evidence-based radiotherapy recommendations were followed by the entire population of lung cancer patients, it is estimated that…

News

5.11.2021

YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…

Press Releases

Testimonials

Hear what people say about us.

Customer Portfolio